Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 2 hours ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR9756Referred to Committee

To direct the Director of the Bureau of Prisons to provide medication assisted treatment for opioid addiction to certain women.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-07-16
Introduced
0
Cosponsors
HR
ⓘ
Type

Sponsor

John J. McGuire III
John J. McGuire III
Republican · VA · Representative
Votes with party: 94.3% (598 recorded votes)

Full profile: /officials/M001239

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on the Judiciary.

2026-07-16

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on the JudiciaryReferred To · 2026-07-16

Plain-English Summary

The federal government would be required to offer medication-assisted treatment for opioid addiction to women in federal prisons, using FDA-approved medications like methadone or buprenorphine to help them manage their addiction. This would affect incarcerated women in the federal prison system who struggle with opioid dependence and would give them access to medical treatment that has been shown to reduce relapse rates and improve outcomes. The Bureau of Prisons would need to implement these treatment programs as part of their healthcare services.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR9633Birthright Citizenship Clarification Act of 2026
    Referred to Committee · 2026-07-09
  • HR9522National Patriot Day Remembrance Flag Act
    Referred to Committee · 2026-06-29
  • HR5103Make the District of Columbia Safe and Beautiful Act of 2025
    Passed House · 2026-06-16
  • HR8843FAFO Act
    Referred to Committee · 2026-05-15